New York, May 21, 2026, 13:05 (EDT)
- NewGenIVF shares climbed as much as 61% to $1.19 in recent trading, with volume topping 85 million shares after reaching an intraday high of $1.50.
- NewGenIVF Group Limited filed a 6-K saying it will take an initial 2% stake in PredicXion Group, also called K25.ai, based on a $100 million pre-money valuation. Pre-money is the value before the investment.
- The filing said the deal still needs due diligence, final paperwork, approvals and other closing steps.
Shares of NewGenIVF Group Limited shot up on Thursday in busy trading on Nasdaq. The Bangkok-based company announced a deal to invest in K25.ai, which runs an AI-driven live-streaming prediction-market platform aimed at Asia.
A low-priced stock that’s been hit by financing issues and reverse splits, and moved away from its original fertility-services business, jumped after the news. Shares traded between $0.7264 and $1.50 and were last at $1.19, up about 61% from the day before.
AI and prediction markets are in focus for investors this year, even among small caps. NewGenIVF filed plans to buy 2% of PredicXion Group, which operates as K25.ai, at a $100 million pre-money valuation and may boost its stake to 10%.
The agreement filed with the SEC puts the initial consideration at $1 million, paid in either cash, stablecoin or Solana, plus 666,667 new NewGenIVF Class A shares at $1.50 apiece. There’s a top-up option of another $4 million, also in cash or crypto, and $4 million in NewGenIVF shares.
K25.ai says it’s putting together a “watch-to-predict” platform. The company is combining live video, creator communities and tools that use AI to help with event creation. Prediction markets let users buy and sell contracts based on what could happen. These contract prices offer a rough take on what people think is likely.
Top spots are getting more crowded as Polymarket and Kalshi turn into more recognized names. The NHL said Thursday it has an information-sharing deal with the U.S. Commodity Futures Trading Commission, as leagues keep an eye on prediction markets. The NHL already works with Polymarket and Kalshi, according to Reuters.
NewGenIVF founder, chairman and CEO Alfred Siu Wing Fung said the deal brings NewGenIVF “exposure to the convergence” of AI, live streaming and creator monetization. Andy Cheung, who leads K25.ai and used to be OKX’s chief operating officer, described K25.ai as a “new generation of interactive markets.” GlobeNewswire
The filing adds a governance twist to the deal. PredicXion can put three independent non-exec directors on NewGenIVF’s board after the close. NewGenIVF picks up a non-voting observer spot on PredicXion’s board. NewGenIVF also gets to be K25.ai’s exclusive agent in Thailand, Singapore, Japan, and certain APAC markets agreed on by both parties, but not Hong Kong. That role comes with a 10% cut of gross profit from any customer it brings in or services.
Trading moves are happening on a lean base. NewGenIVF’s 2025 annual report showed revenue was $4.73 million, down from $5.43 million last year. Revenue came from IVF treatments and fertility referrals. The company reported cash and cash equivalents of about $758,621 as of Dec. 31. It warned about its ability to keep operating as a going concern.
The rally isn’t without risks. The deal hasn’t closed yet. K25.ai can only sell in approved markets. NewGenIVF highlights in its filing that equity lines, warrants, and convertibles could dilute shares. Delays in approvals, the option not getting exercised, or tighter rules on prediction markets could all push the stock back down fast.
Volatility is familiar for this name. Back in March, Nasdaq said NewGenIVF would do a one-for-four reverse stock split, the kind of share move aimed at boosting the per-share price. The annual report also cited more past reverse splits.
The move was notable with the broader market down. Major indexes on Wall Street traded lower around midday with oil prices and Treasury yields both up. Art Hogan, chief market strategist at B Riley Wealth, said any optimism around Iran talks had faded and “oil prices and Treasury yields began moving higher again.” Reuters
Right now, the trade is still about optionality, not earnings. NewGenIVF has latched onto a hot sector, but investors just have a heads-of-agreement with K25.ai in hand, not a done deal or booked revenue yet.
